64 results found.
      
Orthopedic Public Companies Grow 2.6% YoY in Quarter
By Mike Evers The second quarter of 2019 brought incremental improvement over the first. Year over year revenue grew 2.6% in the quarter for the public companies reported herein compared to 1.1% last quarter. The five largest orthopedic players, which control 58% of the market, showed a...
Aurora Spine Posts Record 2Q19 Revenue on Hardware
Aurora Spine reports 2Q19 revenue of USD $3.3MM, +62.8% vs. 2Q18.
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
Aurora Spine Reports 1Q19 Revenue of $2.7MM, +81.2% vs. 1Q18
Aurora Spine reports 1Q19 revenue of USD $2.7MM, +81.2% vs. 1Q18.
Aurora Spine Reports 4Q18 Revenue of $2.5MM, +82.4% vs. 4Q17
Aurora Spine reports 4Q18 revenue of USD $2.5MM, +82.4% vs. 4Q17, with full-year 2018 revenue
Regulatory Report: 42 Companies that Received their First Orthopedic-Related FDA 510(k) in 2018
Small companies around the world and across the orthopedic market segments continue to seek access to the expansive U.S. market. In 2018, 42 companies received their first ever orthopedic-related FDA 510(k) or their first FDA 510(k) in a new market segment. No surprise, the majority of companies ...
Aurora Spine Granted U.S. Patent for Minimally Invasive Spinal Devices
Aurora Spine was granted a U.S. patent, “Expandable Interspinous Device,” covering the company’s family of
Aurora Spine Reports 3Q18 Revenue of $2.7MM, +59.6% vs. 3Q17
Aurora Spine reports 3Q18 revenue of US $2.7MM, +59.6% vs. 3Q17.
Aurora Spine Gains Access to SI Fusion Patent
Aurora Spine acquired an exclusive license to a U.S. patent pertinent to sacroiliac joint repair.
Aurora Spine Granted EU Patent for ZIP Minimally Invasive Spinal Devices
Aurora Spine was granted an EU Patent covering ZIP® interspinous devices.
DePuy Synthes 2Q17 Orthopaedic Revenue
ORTHOWORLD estimates DePuy Synthes’ 2Q17 orthopaedic revenue at US $2,214.8MM, +0.4% vs. 2Q16.
DePuy Synthes Company Profile
We're redesigning Company Profiles. To get the most current news and articles about DePuy Synthes in the interim,
Polyaxial ZIP ISP Technology Available for Out-Licensing
Aurora Spine's proprietary implant locking technology is available for out-licensing or private labeling opportunities....
Aurora Spine Issued U.S. Patent for Polyaxial ZIP
Aurora Spine was issued U.S. Patent No. 9,603,637, "Polyaxial Interspinous Fusion Implant and Bone Growth Stimulation
Aurora Spine Issued U.S. Patent Related to Polyaxial ZIP Technology
Aurora Spine announced the allowance of
K2M Expands 3D-Printed MIS CASCADIA Lateral Interbody System
K2M received FDA 510(k) clearance for additional implant sizes of its CASCADIA™ Late...
Aurora Spine Joins MetroConnect Program to Expand International Growth
Aurora Spine is participating in MetroConnect, an export support program designed to assist companies with
Aurora Spine Issued U.S. Patent Related to ZIP MIS Devices
Aurora Spine was issued U.S. Patent No. 9,364,264, "Dynamic and Non-Dynamic Interspinous Fusion Implant
Aurora Spine Posts 1Q16 Revenue
Aurora Spine posted 1Q16 revenue of US $1.5MM, +19.3% vs. 1Q15 as-reported. 
Aurora Spine 1,000th ZIP MIS Interspinous Device Implanted
Aurora Spine achieved the milestone of
Aurora Spine Posts 3Q15 Revenue
Aurora Spine reported 3Q15 revenue of US $1.17MM, +116% vs. 3Q14. Sales of >640 units in 3Q15 represent an >25% increa...
Investors Shy From Start-Up Risk, Continue to Back Growth-Stage Companies
By Carolyn LaWell Investors continue to back growth-stage device companies and those at the intersection of medical and information technology, as opposed to start-ups—a trend that is expected to endure in 2016. The investment community’s oppositio...
BARE BONES® - August 31, 2015
Aurora Spine posted 2Q15 sales of US $1.1MM, an increase of >100% vs. 2Q14. (U.S. ~$1.02MM, ex-U.S. ~$0.08MM; TiNano® interbody portfolio ~$0.7MM, TiNano Di...
Company Revenue 2015: Aurora Spine
$0.9MM, +102% (U.S. $0.8MM, ex-U.S. $0.06MM) TiNano® interbody portfolio ~$0.5MM (TiNano Discover cervical interbody cage sales +183%) Increased salesforce in central U.S. Initiated surgeries with VOX™ LLIF and EOS™ TLIF systems
BARE BONES® - August 18, 2015
Aurora Spine received CE Mark approval for its full line of TiNano® sterile-packed titanium coated spinal fusion implants, made of PEEK thermoplastic. (
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group